Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (250 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 25 Sep 2024 – 20 Aug 2026, limited by Invesco India Technology Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Invesco India Technology Fund | Nifty 500 |
|---|---|---|
| 25 Sep 2024 | ₹100.00 | ₹100.00 |
| 22 Nov 2024 | ₹98.50 | ₹91.20 |
| 19 Jan 2025 | ₹99.00 | ₹88.96 |
| 18 Mar 2025 | ₹84.22 | ₹84.76 |
| 14 May 2025 | ₹92.61 | ₹92.32 |
| 11 Jul 2025 | ₹96.80 | ₹95.53 |
| 07 Sep 2025 | ₹97.30 | ₹93.67 |
| 04 Nov 2025 | ₹100.00 | ₹97.14 |
| 01 Jan 2026 | ₹100.90 | ₹97.95 |
| 28 Feb 2026 | ₹86.71 | ₹95.06 |
| 26 Apr 2026 | ₹88.01 | ₹92.61 |
| 23 Jun 2026 | ₹93.61 | ₹94.42 |
| 20 Aug 2026 | ₹103.10 | ₹96.48 |
| Metric | Invesco · Direct · IDCW NAV ₹10.32 Very High risk ★★★☆☆ 1Y | Category median Sectoral/ Thematic · 250 funds |
|---|---|---|
| +5.09% | +5.11% | |
| — | +13.02% | |
| — | +11.14% | |
| — | +12.26% | |
| +1.62% | +11.82% | |
| +8.71% | — | |
| — | +14.62% | |
| — | +12.95% | |
| — | +13.24% | |
| Risk | ||
| 18.64% | 15.88% | |
| -0.08 | 0.35 | |
| -0.10 | 0.47 | |
| -28.11% | -25.18% | |
| Nifty 500 | — | |
| — | +1.40% | |
| — | 0.98 | |
| — | 101.5% | |
| — | 97.0% | |
| 1.05% | 1.14% | |
| ₹297.43Cr | ₹1,162Cr | |
| 0.50% | — | |
| None | — | |
| ₹100 | — | |
| ₹1.00K | — | |
| 38% | 45% | |
| Hiten Jain · 2y | — | |
| 25 Sep 2024 | — | |
| 27 | — | |
| 57.1% | — | |
| 1.9% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.